6 ETFs to gain exposure to China market opportunities

China’s market recently saw a significant bounce, driven by a new wave of government stimulus aimed at revitalising the economy.

Investor optimism surged following the government’s commitment to economic growth through measures like liquidity injections and targeted support to the real estate sector.

If you’re looking to gain exposure to this economic recovery, I’ll share some popular exchange-traded funds (ETFs) that provide access to Chinese stocks.

An ETF, or Exchange-Traded Fund, is a basket of investments that trades like a stock.

If I want exposure to a sector or market, like China, I can buy an ETF that holds multiple companies, giving me diversification with one investment.

ETFs track specific indexes or sectors, and they’re popular for being affordable, diversified, and easy to trade.

In China’s complex market, ETFs offer broad exposure while reducing risks from individual stock picking, making them a smart option for navigating regulatory and economic shifts.

Founded in 2008, CSOP was a pioneer in launching China-focused ETFs for international markets, offering investors access to both onshore and offshore Chinese markets.

As one of the largest ETF issuers in Hong Kong, CSOP’s total assets under management surpassed US$15.3 billion by 31 July 2024, cementing its strong market position.

Beyond their size, CSOP’s ETFs are among the most actively traded. In the first seven months of 2024, five of their ETFs ranked in the top 10 most actively traded in Hong Kong, showcasing their popularity and investor trust.

CSOP Asset Management is a subsidiary of China Southern Asset Management, one of China’s largest asset managers, with US$301.4 billion in assets as of 31 March 2024, underscoring its influence in the financial sector.

Earlier, we shared that the factors we would consider when investing in ETFs would include:

– Index methodology and sector exposure

– Dividend yield

– Fees and charges

– Listing exchange

The following is a comparison of the ETFs based on these metrics.

This ETF includes major sectors such as finance, utilities, and telecommunications, featuring Chinese giants like Alibaba and Tencent, along with international firms with China exposure, such as AIA and HSBC.

With a low management fee of 0.1% p.a., the CSOP Hang Seng Index ETF offers a cost-effective way to gain broad exposure to China’s market. Its sector diversification also helps mitigate risks compared to more concentrated indices, such as those focused solely on technology.

In addition, Hong Kong’s financial market is highly liquid and operates under a strong regulatory framework, providing investors with greater transparency especially during periods of market volatility.

This ETF focuses on blue-chip stocks, including major financial institutions like Bank of China, ICBC, and Ping An Insurance, along with consumer leaders like Kweichow Moutai, China’s top baijiu producer.

However, the A50 index does not include popular tech giants such as Alibaba and Tencent, as the majority of its constituents are in more traditional sectors within China’s onshore markets.

The CSOP Hang Seng Tech ETF focuses on leading technology firms listed in Hong Kong, capturing opportunities in China's tech sector.

This would include names such as Alibaba, Tencent and Xiaomi.

Notably, the CSOP Hang Seng Tech Index ETF has assets under management of HKD 39.2 billion as of 16 October 2024, which is the biggest traded ETF tracking Hang Seng Tech Index in the world.

It is also the top 3 most actively traded ETFs in Hong Kong, with an average trading value of HK$ 1.7 billion from January to July 2024.

This ETF aims to amplify short-term returns, but it also increases risks, making it suitable for investors seeking to capitalize on short-term market movements.

For example, we see that the CSOP CSI 300 Index Daily (2x) Leveraged Product generated a positive return of +43.8% in the one month to 30 September 2024, exceeding the returns of the CSOP Hang Seng Tech Index ETF and CSOP Hang Seng Index ETF in a buoyant market environment.

Given its higher risk profile, I would only consider the CSOP CSI 300 Index Daily (2x) Leveraged Product if I have a high-risk tolerance.

This would include companies such as China Merchants Bank, which has a dividend yield of 5.1% as of 17 October 2024.

As of 30 September 2024, the dividend yield of the SSE Dividend Index is 5.40%.

This is above the dividend yield of the Hang Seng Index of 3.51%, and the dividend yield of the FTSE China A50 Index of 2.85%,

The CSOP Huatai-PineBridge SSE Dividend Index ETF trades on the Singapore Exchange, and you can buy the ETF using your SRS funds.

This would include names such as Contemporary Amperex Technology (CATL), the leading global EV battery manufacturer and supplier to Tesla.

The CSOP Huatai-PineBridge SSE Dividend Index ETF trades on the Singapore Exchange, and you can buy the ETF using your SRS funds.

While all the listed ETFs have delivered positive year-to-date returns, I’ve noticed that several experienced significant losses in prior years.

For example, the Hang Seng Tech Index ETF faced losses from 2021 to 2023, reflecting the tough challenges China’s tech sector faced due to regulatory crackdowns and global market pressures.

In addition, leveraged products can offer the potential for high returns, but they come with substantial risk.

On the other hand, broad index and dividend-focused ETFs provide more conservative options, balancing income with the potential for moderate growth—an approach I’d consider if I’m aiming for steadier returns over time.

With the Chinese government ramping up stimulus efforts, I think it might be a good time to take another look at the China market.

There are several ways investors can gain exposure to this market.

The investment product(s) mentioned in this material is/are authorized by the Securities and Futures Commission ("SFC") in Hong Kong or registered under section 286 of the Securities and Futures Act (Cap. 289) of Singapore (the “SFA”). Such authorization or registration does not imply any official recommendation by the SFC or Monetary Authority of Singapore (“MAS”). This material and the information contained in this material shall not be regarded as an offer or solicitation of business in any jurisdiction to any person to whom it is unlawful to offer or solicit business in such jurisdictions.

This material and the information contained in it are for general information only and do not constitute financial, professional, investment or any other kind of advice in any way and shall not be considered as an offer or solicitation to deal in any investment products. If you wish to receive advice on investment, please consult your professional legal, tax and financial advisers.

This material is prepared on the believes that information in this material is based upon sources that are believed to be accurate, complete, and reliable. However, we do not warrant the accuracy and completeness of the information, and shall not be liable to the recipient or controlling shareholders of the recipient resulting from its use. We are under no obligation to keep the information up-to-date.

Investment involves risks. Past performance information presented is not indicative of future performance. Investors should refer to the offering documents for further details, including risk factors. Investors should not rely on this material alone to make investment decisions.

This material has not been reviewed by the Securities and Futures Commission in Hong Kong or the Monetary Authority of Singapore.